| scholarly article | Q13442814 |
| P50 | author | Ginger Lohr Milne | Q42289929 |
| P2093 | author name string | Wei Xing | |
| Heng Chhay | |||
| Joshua A Boyce | |||
| Molly S Kidder | |||
| Tanya M Laidlaw | |||
| Neil Bhattacharyya | |||
| Shiliang Shen | |||
| Mariana C Castells | |||
| P2860 | cites work | Purification of human lung leukotriene C4 synthase and preparation of a polyclonal antibody | Q24317133 |
| Expression cloning of a cDNA for human leukotriene C4 synthase, an integral membrane protein conjugating reduced glutathione to leukotriene A4 | Q24564369 | ||
| Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma | Q24564777 | ||
| Platelets amplify inflammation in arthritis via collagen-dependent microparticle production | Q24627618 | ||
| Leukotriene E4-induced pulmonary inflammation is mediated by the P2Y12 receptor | Q24647514 | ||
| Prevalence of asthma with aspirin hypersensitivity in the adult population of Poland | Q28165446 | ||
| Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease | Q28195300 | ||
| Expression of 5-lipoxygenase and cyclooxygenase pathway enzymes in nasal polyps of patients with aspirin-intolerant asthma | Q28196323 | ||
| Increase in urinary leukotriene B4 glucuronide concentration in patients with aspirin-intolerant asthma after intravenous aspirin challenge | Q28210320 | ||
| Transcellular lipoxygenase metabolism between monocytes and platelets | Q28342927 | ||
| Down-regulation of platelet surface CD47 expression in Escherichia coli O157:H7 infection-induced thrombocytopenia | Q28390993 | ||
| Complete reversal of acid-induced acute lung injury by blocking of platelet-neutrophil aggregation | Q30442280 | ||
| Platelets are necessary for airway wall remodeling in a murine model of chronic allergic inflammation | Q33356884 | ||
| Eosinophil hematopoietins antagonize the programmed cell death of eosinophils. Cytokine and glucocorticoid effects on eosinophils maintained by endothelial cell-conditioned medium | Q34214952 | ||
| Platelet-derived serotonin links vascular disease and tissue fibrosis | Q34973681 | ||
| Activation of beta1 integrins on blood eosinophils by P-selectin | Q35528037 | ||
| Regulation of human eosinophil viability, density, and function by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibroblasts | Q36353710 | ||
| Role of vascular cell adhesion molecule 1/very late activation antigen 4 and intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 interactions in antigen-induced eosinophil and T cell recruitment into the tissue | Q36362962 | ||
| T helper cell type 2 cytokines coordinately regulate immunoglobulin E-dependent cysteinyl leukotriene production by human cord blood-derived mast cells: profound induction of leukotriene C(4) synthase expression by interleukin 4. | Q36376120 | ||
| Comparative airway and vascular activities of leukotrienes C-1 and D in vivo and in vitro | Q36399417 | ||
| Effect of endobronchial aspirin challenge on inflammatory cells in bronchial biopsy samples from aspirin-sensitive asthmatic subjects | Q36505616 | ||
| P-selectin cross-links PSGL-1 and enhances neutrophil adhesion to fibrinogen and ICAM-1 in a Src kinase-dependent, but GPCR-independent mechanism | Q37079911 | ||
| Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity. | Q40768651 | ||
| Correlation between expression of 5-lipoxygenase-activating protein, 5-lipoxygenase, and cellular leukotriene synthesis | Q41714750 | ||
| Metabolism of arachidonic acid in polymorphonuclear leukocytes. Structural analysis of novel hydroxylated compounds | Q41739587 | ||
| A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation | Q41824616 | ||
| Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma. A randomized controlled trial. Zileuton Clinical Trial Group | Q42556993 | ||
| Antibody to very late activation antigen 4 prevents antigen-induced bronchial hyperreactivity and cellular infiltration in the guinea pig airways | Q42942539 | ||
| Pharmacodynamics and pharmacokinetics of AM103, a novel inhibitor of 5-lipoxygenase-activating protein (FLAP). | Q43150802 | ||
| Inhaled leukotriene E(4), but not leukotriene D(4), increased airway inflammatory cells in subjects with atopic asthma | Q43796672 | ||
| Effects of montelukast and beclomethasone on airway function and asthma control | Q44237810 | ||
| Montelukast is only partially effective in inhibiting aspirin responses in aspirin-sensitive asthmatics | Q44675978 | ||
| Platelet binding to monocytes increases the adhesive properties of monocytes by up-regulating the expression and functionality of beta1 and beta2 integrins | Q46895647 | ||
| Release of leukotriene A4 versus leukotriene B4 from human polymorphonuclear leukocytes. | Q54136543 | ||
| Polymorphonuclear leukocyte-platelet interaction: role of P-selectin in thromboxane B2 and leukotriene C4 cooperative synthesis | Q58411995 | ||
| Time-dependent utilization of platelet arachidonic acid by the neutrophil in formation of 5-lipoxygenase products in platelet-neutrophil co-incubations | Q67505540 | ||
| Urinary Leukotriene E4Concentrations Increase after Aspirin Challenge in Aspirin-sensitive Asthmatic Subjects | Q67915846 | ||
| Identification of non-cyclooxygenase-derived prostanoid (F2-isoprostane) metabolites in human urine and plasma | Q70578946 | ||
| Improved assay for the quantification of 11-dehydrothromboxane B2 by gas chromatography-mass spectrometry | Q70648774 | ||
| Mass spectrometry of prostanoids: F2-isoprostanes produced by non-cyclooxygenase free radical-catalyzed mechanism | Q72024438 | ||
| Leukotriene C4 formation by transcellular biosynthesis | Q72029852 | ||
| Direct evidence for a role of the mast cell in the nasal response to aspirin in aspirin-sensitive asthma | Q72352958 | ||
| Albumin stabilizes leukotriene A4 | Q72926674 | ||
| Differential metabolism of exogenous and endogenous arachidonic acid in human neutrophils | Q73019291 | ||
| Human platelets produce granulocyte-macrophage colony-stimulating factor and delay eosinophil apoptosis | Q73270475 | ||
| Induction of cytokine expression in leukocytes by binding of thrombin-stimulated platelets | Q73384671 | ||
| Activation of platelets in bronchial asthma | Q74304417 | ||
| Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics | Q74490010 | ||
| Association of urinary leukotriene E4 excretion during aspirin challenges with severity of respiratory responses | Q78247441 | ||
| Platelet P-selectin is required for pulmonary eosinophil and lymphocyte recruitment in a murine model of allergic inflammation | Q80967764 | ||
| Platelet binding to monocytes increases the adhesive properties of monocytes by up-regulating the expression and functionality of β1 and β2 integrins | Q95822730 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 16 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell biology | Q7141 |
| respiratory disease | Q3286546 | ||
| aspirin | Q18216 | ||
| P304 | page(s) | 3790-8 | |
| P577 | publication date | 2012-04-19 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes | |
| P478 | volume | 119 |
| Q28079332 | A Review of Classification Schemes for Chronic Rhinosinusitis with Nasal Polyposis Endotypes |
| Q28294597 | A review on leukotrienes and their receptors with reference to asthma |
| Q89064053 | A trial of type 12 purinergic (P2Y12) receptor inhibition with prasugrel identifies a potentially distinct endotype of patients with aspirin-exacerbated respiratory disease |
| Q42576928 | Activation of group 2 innate lymphoid cells: a new role for cysteinyl leukotrienes |
| Q47678797 | An update on the management of aspirin-exacerbated respiratory disease |
| Q64083734 | Aspirin Exacerbated Respiratory Disease: Epidemiology, Pathophysiology, and Management |
| Q30384450 | Aspirin activation of eosinophils and mast cells: implications in the pathogenesis of aspirin-exacerbated respiratory disease |
| Q42129014 | Aspirin induces IL-4 production: augmented IL-4 production in aspirin-exacerbated respiratory disease |
| Q90523162 | Aspirin sensitivity: Lessons in the regulation (and dysregulation) of mast cell function |
| Q38609538 | Aspirin-Exacerbated Diseases: Advances in Asthma with Nasal Polyposis, Urticaria, Angioedema, and Anaphylaxis |
| Q36119388 | Aspirin-Exacerbated Respiratory Disease Involves a Cysteinyl Leukotriene-Driven IL-33-Mediated Mast Cell Activation Pathway |
| Q38973949 | Aspirin-Exacerbated Respiratory Disease as an Endotype of Chronic Rhinosinusitis |
| Q38931124 | Aspirin-exacerbated respiratory disease and current treatment modalities |
| Q30238776 | Aspirin-exacerbated respiratory disease: Prevalence, diagnosis, treatment, and considerations for the future |
| Q38455960 | Aspirin-exacerbated respiratory disease: characteristics and management strategies |
| Q26750424 | Aspirin-exacerbated respiratory disease: pathophysiological insights and clinical advances |
| Q40901391 | Association of TRPM3 Polymorphism (rs10780946) and Aspirin-Exacerbated Respiratory Disease (AERD). |
| Q28238927 | Biological effects of leukotriene E4 on eosinophils |
| Q35576575 | Biology of nasal polyposis |
| Q33573879 | Characterization of platelet-monocyte complexes in HIV-1-infected individuals: possible role in HIV-associated neuroinflammation |
| Q30278686 | Chronic Rhinosinusitis: More Than Just "Asthma of the Upper Airway" |
| Q37236776 | Clustering drug-drug interaction networks with energy model layouts: community analysis and drug repurposing |
| Q64102598 | Computed Tomography Findings in Patients with Samter's Triad: An Observational Study |
| Q89468973 | Current and Future Treatments of Rhinitis and Sinusitis |
| Q39000200 | Current complications and treatment of aspirin-exacerbated respiratory disease |
| Q42153378 | Cutting edge: Leukotriene C4 activates mouse platelets in plasma exclusively through the type 2 cysteinyl leukotriene receptor |
| Q42118581 | Cysteinyl leukotriene E4 activates human group 2 innate lymphoid cells and enhances the effect of prostaglandin D2 and epithelial cytokines |
| Q91142640 | Cysteinyl leukotriene receptor 2 drives lung immunopathology through a platelet and high mobility box 1-dependent mechanism |
| Q38038319 | Cysteinyl leukotriene receptors, old and new; implications for asthma |
| Q28243252 | Cysteinyl leukotrienes and their receptors; emerging concepts |
| Q36128536 | Cytokines in Chronic Rhinosinusitis. Role in Eosinophilia and Aspirin-exacerbated Respiratory Disease |
| Q37406340 | Diagnostic Utility of Urinary LTE4 in Asthma, Allergic Rhinitis, Chronic Rhinosinusitis, Nasal Polyps, and Aspirin Sensitivity |
| Q47713321 | Dietary Fatty Acid Modification for the Treatment of Aspirin-Exacerbated Respiratory Disease: A Prospective Pilot Trial. |
| Q30829121 | Directed transport of neutrophil-derived extracellular vesicles enables platelet-mediated innate immune response |
| Q28079269 | Eicosanoid Mediators in the Airway Inflammation of Asthmatic Patients: What is New? |
| Q30276354 | Eosinophil production of prostaglandin D2 in patients with aspirin-exacerbated respiratory disease |
| Q30275780 | Eosinophils and Mast Cells in Aspirin-Exacerbated Respiratory Disease |
| Q37405580 | Exploration of the Sphingolipid Metabolite, Sphingosine-1-phosphate and Sphingosine, as Novel Biomarkers for Aspirin-exacerbated Respiratory Disease. |
| Q38085051 | Immunopathogenesis of allergic disorders: current concepts |
| Q38814643 | Is there a future for biologics in the management of chronic rhinosinusitis? |
| Q89782904 | Le syndrome de Widal en pratique clinique |
| Q28275552 | Leukotriene E4 elicits respiratory epithelial cell mucin release through the G-protein-coupled receptor, GPR99 |
| Q27023936 | Lipid mediators and allergic diseases |
| Q99575721 | Lipid-mediated innate lymphoid cell recruitment and activation in AERD |
| Q34986906 | Lipoxin generation is related to soluble epoxide hydrolase activity in severe asthma |
| Q54351738 | Mass cytometry profiling the response of basophils and the complete peripheral blood compartment to peanut. |
| Q47964479 | Microparticles in nasal lavage fluids in chronic rhinosinusitis: Potential biomarkers for diagnosis of aspirin-exacerbated respiratory disease. |
| Q90330860 | NSAID-ERD Syndrome: the New Hope from Prevention, Early Diagnosis, and New Therapeutic Targets |
| Q36504328 | P2Y12 antagonist attenuates eosinophilic inflammation and airway hyperresponsiveness in a mouse model of asthma |
| Q37098084 | PLA2G5 regulates transglutaminase activity of human IL-4-activated M2 macrophages through PGE2 generation |
| Q64912616 | Pathogenesis of NSAID-induced reactions in aspirin-exacerbated respiratory disease. |
| Q38103710 | Pathogenesis of aspirin-exacerbated respiratory disease and reactions |
| Q50984877 | Pharmacogenetic tests to predict the efficacy of aspirin desensitization in patients with aspirin-exacerbated respiratory diseases; HLA-DQB302. |
| Q41334017 | Platelet-Eosinophil Interactions As a Potential Therapeutic Target in Allergic Inflammation and Asthma |
| Q34473270 | Platelet-driven leukotriene C4-mediated airway inflammation in mice is aspirin-sensitive and depends on T prostanoid receptors |
| Q38202705 | Platelets and allergic inflammation. |
| Q26739670 | Platelets in Pulmonary Immune Responses and Inflammatory Lung Diseases |
| Q28080840 | Platelets in patients with aspirin-exacerbated respiratory disease |
| Q47178294 | Platelets: an outlook from biology through evidence-based achievements in critical care |
| Q41500425 | Potential Biomarkers for NSAID-Exacerbated Respiratory Disease |
| Q37240446 | Prostaglandin E2 deficiency causes a phenotype of aspirin sensitivity that depends on platelets and cysteinyl leukotrienes |
| Q36140425 | Prostaglandin E2 deficiency uncovers a dominant role for thromboxane A2 in house dust mite-induced allergic pulmonary inflammation |
| Q33693274 | Prostaglandin E2 resistance in granulocytes from patients with aspirin-exacerbated respiratory disease |
| Q59791517 | Role of Platelets in Leukocyte Recruitment and Resolution of Inflammation |
| Q90077678 | Suppression of aspirin-mediated eosinophil activation by prostaglandin E2: Relevance to aspirin and nonsteroidal anti-inflammatory drug hypersensitivity |
| Q43475763 | Systemic prednisone administration selectively alters granulocyte subsets in nasal polyps from aspirin-exacerbated respiratory disease and chronic rhinosinusitis patients |
| Q61821929 | The Possible Role of Helicobacter pylori in Gastric Cancer and Its Management |
| Q92127138 | The Role of Leukotrienes as Potential Therapeutic Targets in Allergic Disorders |
| Q39320449 | The expansive role of oxylipins on platelet biology. |
| Q64058686 | The synergistic effects of clopidogrel with montelukast may be beneficial for asthma treatment |
| Q58098733 | The utility of biomarkers in diagnosis of aspirin exacerbated respiratory disease |
| Q36357862 | The whole-genome expression analysis of peripheral blood mononuclear cells from aspirin sensitive asthmatics versus aspirin tolerant patients and healthy donors after in vitro aspirin challenge |
| Q39093155 | Update on Aspirin-Exacerbated Respiratory Disease |
| Q26749097 | Update on the Management of Aspirin-Exacerbated Respiratory Disease |
Search more.